Innovate UK has up to £1 million for UK businesses to collaborate with partners in India and Europe on healthcare projects targeted at the Indian market. The investment comes through the Newton Fund. This aims to harness the best of UK research and in… read more
The joint guidance published on 6 August outlines what it would mean for market access for medicines during the implementation period, including; licensing and packaging, batch release and testing, and the UK regulatory role. It also covers other points relating … read more
The joint guidance published on 6 August outlines what it would mean for market access for medicines during the implementation period, including; licensing and packaging, batch release and testing, and the UK regulatory role. It also covers other poin… read more
As part of exit negotiations, MHRA is working to ensure that we continue to have the best possible environment in which to support clinical trials. Our overall aim is to ensure that patients in the UK and across the EU … read more
As part of exit negotiations, MHRA is working to ensure that we continue to have the best possible environment in which to support clinical trials. Our overall aim is to ensure that patients in the UK and across the EU continue to be able to access th… read more